These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12056702)

  • 1. Relevance of intraocular involvement in the management of primary central nervous system lymphomas.
    Ferreri AJ; Blay JY; Reni M; Pasini F; Gubkin A; Tirelli U; Calderoni A; Zucca E; Cortelazzo S; Chassagne C; Tinguely M; Borisch B; Berger F; Ponzoni M; Cavalli F;
    Ann Oncol; 2002 Apr; 13(4):531-8. PubMed ID: 12056702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular involvement is associated with a high risk of disease relapse in primary central nervous system lymphoma.
    Zhuang L; Lai J; Chen K; Ding T; Yuan Y; Ma Y; Kang H; Lin Z; Fan N; Ma J; Zeng Q; Xu X; Wang Q; Chen B
    Oncol Rep; 2019 Jan; 41(1):397-404. PubMed ID: 30320386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of radiotherapy in 1054 patients with primary central nervous system lymphoma treated from 1985 to 2009.
    Shibamoto Y; Sumi M; Takemoto M; Tsuchida E; Onodera S; Matsushita H; Sugie C; Tamaki Y; Onishi H
    Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):653-60. PubMed ID: 25034088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.
    Ferreri AJ; Reni M; Dell'Oro S; Ciceri F; Bernardi M; Camba L; Ponzoni M; Terreni MR; Tomirotti M; Spina M; Villa E
    Oncology; 2001; 60(2):134-40. PubMed ID: 11244328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular lymphoma 2000-2005: results of a retrospective multicentre trial.
    Jahnke K; Korfel A; Komm J; Bechrakis NE; Stein H; Thiel E; Coupland SE
    Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):663-9. PubMed ID: 16228920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma.
    O'Brien P; Roos D; Pratt G; Liew K; Barton M; Poulsen M; Olver I; Trotter G
    J Clin Oncol; 2000 Feb; 18(3):519-26. PubMed ID: 10653867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined modality therapy for primary CNS lymphoma.
    DeAngelis LM; Yahalom J; Thaler HT; Kher U
    J Clin Oncol; 1992 Apr; 10(4):635-43. PubMed ID: 1548527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
    Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
    Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.
    Poortmans PM; Kluin-Nelemans HC; Haaxma-Reiche H; Van't Veer M; Hansen M; Soubeyran P; Taphoorn M; Thomas J; Van den Bent M; Fickers M; Van Imhoff G; Rozewicz C; Teodorovic I; van Glabbeke M;
    J Clin Oncol; 2003 Dec; 21(24):4483-8. PubMed ID: 14597741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials.
    Ferreri AJ; Reni M; Villa E
    Ann Oncol; 2000 Aug; 11(8):927-37. PubMed ID: 11038028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of intraocular involvement in primary CNS lymphoma: experience from the G-PCNSL-SG1 trial.
    Kreher S; Strehlow F; Martus P; Roth P; Hertenstein B; Röth A; Birnbaum T; Griesinger F; Rauch M; Kanz L; Thiel E; Weller M; Korfel A
    Ann Hematol; 2015 Mar; 94(3):409-14. PubMed ID: 25217230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report.
    Grimm SA; Pulido JS; Jahnke K; Schiff D; Hall AJ; Shenkier TN; Siegal T; Doolittle ND; Batchelor T; Herrlinger U; Neuwelt EA; Laperriere N; Chamberlain MC; Blay JY; Ferreri AJ; Omuro AM; Thiel E; Abrey LE
    Ann Oncol; 2007 Nov; 18(11):1851-5. PubMed ID: 17804469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
    Mappa S; Marturano E; Licata G; Frezzato M; Frungillo N; Ilariucci F; Stelitano C; Ferrari A; Sorarù M; Vianello F; Baldini L; Proserpio I; Foppoli M; Assanelli A; Reni M; Caligaris-Cappio F; Ferreri AJ
    Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma.
    Fishburne BC; Wilson DJ; Rosenbaum JT; Neuwelt EA
    Arch Ophthalmol; 1997 Sep; 115(9):1152-6. PubMed ID: 9298056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement.
    Smith JR; Rosenbaum JT; Wilson DJ; Doolittle ND; Siegal T; Neuwelt EA; Pe'er J
    Ophthalmology; 2002 Sep; 109(9):1709-16. PubMed ID: 12208721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
    Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J
    J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment.
    Hormigo A; Abrey L; Heinemann MH; DeAngelis LM
    Br J Haematol; 2004 Jul; 126(2):202-8. PubMed ID: 15238140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain radiotherapy in patients treated for a newly diagnosed primary central nervous system lymphoma: professional practice evaluation in 19 French centers.
    Thomas-Joulié A; Houillier C; Antoni D; Créhange G; Jouglar E; Colin P; Benchalal M; Lang P; Alfonsi M; Hamidou H; Coutte A; Ahrweiller F; Dadoun N; Pointreau Y; Ammarguellat H; Bernier-Chastagner V; Belkacemi Y; Vieillot S; Hoang-Xuan K; Soussain C; Jacob J; Feuvret L
    Acta Oncol; 2023 Jun; 62(6):648-656. PubMed ID: 37338525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular lymphoma: report of three cases and review of the literature.
    Trudeau M; Shepherd FA; Blackstein ME; Gospodarowicz M; Fitzpatrick P; Moffatt KP
    Am J Clin Oncol; 1988 Apr; 11(2):126-30. PubMed ID: 3282423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.